8-K: RMG Acquisition Corp. III Faces Delisting Threat Despite Regaining Market Value Compliance
Current Report
RMG Acquisition Corp. III received a second delisting notice from Nasdaq for failing to complete a business combination within the required timeframe, despite regaining compliance with the minimum market value standard.
Summary
- RMG Acquisition Corp. III received a delisting notice from Nasdaq due to not meeting the minimum Market Value of Listed Securities (MVLS) requirement of US$35 million.
- The company was given until December 18, 2023, to regain compliance, but failed to do so, leading to a determination letter from Nasdaq on December 20, 2023.
- RMG requested a hearing before the Nasdaq Hearings Panel, which stayed the delisting action.
- A hearing is scheduled for March 21, 2024, to address the delisting issue.
- On February 5, 2024, RMG received a second notice for failing to complete a business combination within 36 months of its IPO.
- On February 8, 2024, the company received notice that it had regained compliance with the Market Value Standard, closing the initial delisting issue.
- The upcoming hearing will now focus on the failure to complete a business combination, with RMG presenting its plan to complete the merger with H2B2 Electrolysis Technologies, Inc.
- The company's shareholders approved an extension to the deadline to complete a business combination from February 9, 2024, to April 9, 2024, with the possibility of further extensions up to August 9, 2024.
- 8 shareholders elected to redeem 80,694 Class A Ordinary Shares, representing approximately 1.95% of the issued and outstanding Class A Ordinary Shares.
Sentiment
Score: 3
Explanation: The document highlights significant challenges, including a second delisting notice and uncertainty about the business combination, leading to a negative sentiment.
Positives
- RMG Acquisition Corp. III has regained compliance with the Nasdaq's minimum Market Value of Listed Securities (MVLS) requirement.
- Shareholders have approved an extension to the deadline for completing a business combination, providing additional time to finalize the merger with H2B2 Electrolysis Technologies, Inc.
Negatives
- RMG Acquisition Corp. III received a second delisting notice from Nasdaq for failing to complete a business combination within the required timeframe.
- There is no assurance that the Nasdaq Hearings Panel will grant the company's request for continued listing or that the business combination will be completed within the extended timeframe.
- A small percentage of shareholders, 1.95%, elected to redeem their shares, indicating some level of uncertainty or dissatisfaction.
Risks
- The Nasdaq Hearings Panel may not grant an extension for the company to complete its business combination.
- The company may not be able to complete the business combination with H2B2 Electrolysis Technologies, Inc. within the extended timeframe.
- Failure to complete the business combination could lead to the delisting of the company's shares and liquidation of the trust account.
- There is a risk that the company may not be able to meet the requirements for initial listing on the Nasdaq Capital Market after the business combination.
Future Outlook
The company is working to complete the business combination with H2B2 Electrolysis Technologies, Inc. and is seeking an extension from the Nasdaq Hearings Panel to do so. There is no guarantee that the extension will be granted or that the business combination will be completed.
Management Comments
- The Company will address the Additional Basis Issue by presenting its plan to complete the previously announced proposed business combination with H2B2 Electrolysis Technologies, Inc.
- The Company is working with all due haste to complete the Business Combination.
Industry Context
The special purpose acquisition company (SPAC) market has seen increased scrutiny and challenges, with many companies struggling to complete business combinations within the required timeframes. This situation reflects the broader difficulties faced by SPACs in the current market environment.
Comparison to Industry Standards
- Many SPACs have faced similar challenges in meeting listing requirements and completing business combinations within the allotted time.
- The 36-month deadline for completing a business combination is a standard requirement for SPACs listed on Nasdaq.
- The minimum market value requirement of US$35 million is also a common benchmark for continued listing on the Nasdaq Capital Market.
- The redemption rate of 1.95% is relatively low compared to some other SPACs facing similar issues, which have seen much higher redemption rates.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Articles of Association | The company amended its Amended and Restated Memorandum and Articles of Association to extend the deadline for completing a business combination. | February 7, 2024 | The amendment provides additional time for the company to complete its business combination, but does not guarantee success. |
Stakeholder Impact
- Shareholders face the risk of delisting and potential loss of investment if the business combination is not completed.
- Employees may experience uncertainty regarding their future employment due to the company's precarious situation.
- Customers and suppliers may be affected by the company's potential delisting and liquidation.
Next Steps
- The company will present its plan to complete the business combination with H2B2 Electrolysis Technologies, Inc. at the Nasdaq Hearings Panel hearing on March 21, 2024.
- The company will seek an extension from the Nasdaq Hearings Panel to complete the business combination.
- The company will mail a definitive Proxy Statement/Prospectus to its shareholders for voting on the Business Combination.
Key Dates
| Date | Description |
|---|---|
| February 9, 2021 | Date of the company's initial public offering (IPO). |
| June 20, 2023 | Date the company received the initial deficiency letter from Nasdaq regarding the minimum Market Value of Listed Securities (MVLS). |
| June 26, 2023 | Date the company reported the initial deficiency letter on Form 8-K. |
| December 18, 2023 | Original deadline for the company to regain compliance with the Market Value Standard. |
| December 20, 2023 | Date the company received a determination letter from Nasdaq stating it had not regained compliance with the Market Value Standard. |
| December 27, 2023 | Date the company reported the determination letter on Form 8-K. |
| January 16, 2024 | Record date for the Extraordinary General Meeting. |
| February 5, 2024 | Date the company received a second delisting notice from Nasdaq for failing to complete a business combination within 36 months of its IPO. |
| February 7, 2024 | Date of the Extraordinary General Meeting where shareholders approved the extension to the business combination deadline. |
| February 8, 2024 | Date the company received notice that it had regained compliance with the Market Value Standard. |
| February 9, 2024 | Original deadline for the company to complete a business combination. |
| March 21, 2024 | Date of the hearing before the Nasdaq Hearings Panel. |
| April 9, 2024 | Extended deadline for the company to complete a business combination. |
| August 3, 2024 | Latest possible date the Panel can grant an extension to complete the business combination. |
| August 9, 2024 | Latest possible date for the company to complete a business combination with all extensions. |
Keywords
delisting, business combination, Nasdaq, RMG Acquisition Corp. III, H2B2 Electrolysis Technologies, merger, extension, shareholder redemption, market value, hearing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.